M S Ramer
Overview
Explore the profile of M S Ramer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
697
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Manesh S, Kondiles B, Wheeler S, Liu J, Zhang L, Chernoff C, et al.
J Neurochem
. 2024 Sep;
169(1):e16220.
PMID: 39268880
The development of therapeutic strategies to reduce impairments following spinal cord injury (SCI) motivates an active area of research, because there are no effective therapies. One strategy is to address...
2.
Oudega M, Bradbury E, Ramer M
Handb Clin Neurol
. 2012 Oct;
109:617-36.
PMID: 23098740
Spinal cord injury (SCI) has multiple consequences, ranging from molecular imbalances to glial scar formation to functional impairments. It is logical to think that a combination of single treatments implemented...
3.
Cragg J, Scott A, Ramer M
Exp Neurol
. 2010 Jan;
222(2):277-84.
PMID: 20079735
Dorsal root injuries (DRIs), resulting in the permanent disconnection of nerve roots from the spinal cord, lead to sensory impairments, including both the loss of sensation and the development of...
4.
Hanna-Mitchell A, OLeary D, Mobarak M, Ramer M, McMahon S, Priestley J, et al.
Spinal Cord
. 2008 Jun;
46(12):804-10.
PMID: 18542093
Study Design: Morphological and Stereological assessment of the dorsal root transitional zone (DRTZ) following complete crush injury, using light microscopy (LM) and transmission electron microscopy (TEM). Objectives: To assess the...
5.
Inskip J, Ramer L, Ramer M, Krassioukov A
Spinal Cord
. 2008 Jun;
47(1):2-35.
PMID: 18542091
Study Design: Literature review. Objectives: To present a comprehensive overview of autonomic assessment in experimental spinal cord injury (SCI). Methods: A systematic literature review was conducted using PubMed to extract...
6.
Gaudet A, Steeves J, Tetzlaff W, Ramer M
Curr Drug Targets
. 2005 Jul;
6(4):419-25.
PMID: 16026260
Galectin-1 (Gal1) was the first identified member of the galectin family of beta-galactosidase-binding proteins. Gal1 has important roles in processes fundamental to growth and survival of an organism, including cell...
7.
McGraw J, Gaudet A, Oschipok L, Kadoya T, Horie H, Steeves J, et al.
Exp Neurol
. 2005 May;
195(1):103-14.
PMID: 15893752
Galectin-1 (Gal1) is an endogenously-expressed protein important for the embryonic development of the full complement of primary sensory neurons and their synaptic connections in the spinal cord. Gal1 also promotes...
8.
McGraw J, Gaudet A, Oschipok L, Steeves J, Poirier F, Tetzlaff W, et al.
Pain
. 2005 Mar;
114(1-2):7-18.
PMID: 15733626
The transmission of nociceptive information occurs along non-myelinated, or thinly myelinated, primary afferent axons. These axons are generally classified as peptidergic (CGRP-expressing) or non-peptidergic (IB4-binding), although there is a sub-population...
9.
Ramer L, Ramer M, Steeves J
Spinal Cord
. 2005 Jan;
43(3):134-61.
PMID: 15672094
Here we review mechanisms and molecules that necessitate protection and oppose axonal growth in the injured spinal cord, representing not only a cast of villains but also a company of...
10.
McGraw J, McPhail L, Oschipok L, Horie H, Poirier F, Steeves J, et al.
Eur J Neurosci
. 2004 Dec;
20(11):2872-80.
PMID: 15579141
The exogenous application of recombinant galectin-1 has recently been shown to promote the rate of peripheral nerve regeneration. Endogenous neuronal galectin-1 expression has recently been demonstrated to increase after axotomy....